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Abstract 
Lower Levels of Physical Activity Are Associated with Increased Severity of Chemotherapy-
Induced Peripheral Neuropathy in Cancer Survivors 
By Anna Wilcoxon 
Limited information exists on the effects of self-reported exercise on subjective and 
objective measures of chemotherapy-induced peripheral neuropathy (CIPN). In this study, we 
evaluated for differences in demographic and clinical characteristics, as well as subjective and 
objective measures of CIPN and balance among 290 cancer survivors with CIPN who were 
classified into one of three exercise (Ex) groups (i.e., NoEx, LessEx, RecEX) based on the 
recommended level of >150 minutes per week. Survivors completed self-report questionnaires 
and underwent a sensory examination and balance testing. Compared to RecEx group (34.8%), 
survivors in the NoEx group (20.7%) had less education, were less likely to be 
married/partnered, had a lower household income, a higher level of comorbidity, and a poorer 
functional status. No differences were found among the three exercise groups in duration of 
CIPN, pain intensity scores, or changes in light touch, cold and pain sensations. However, 
compared to the RecEx group, survivors in the NoEx group had higher vibratory thresholds and 
worse scores on objective measures of balance. Based on our ³real world´ findings, clinicians 
can recommend walking as a therapeutic option, as well as referrals to physical therapy for 
additional balance and strength training in survivors with CIPN. 
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Introduction 
Chemotherapy-induced peripheral neuropathy (CIPN) occurs in 30% to 50% of cancer 
survivors28,61 has negative effects on patient outcomes,10,29 and is associated with an increased 
risks of falls.29 While duloxetine is the only drug recommended to decrease CIPN pain,22 a 
growing body of evidence suggests that regular physical activity is a safe and low cost 
intervention to decrease the severity of CIPN symptoms.1,56 While the mechanisms that underlie 
the efficacy of exercise are not completely understood, findings from preclinical studies suggest 
that physical exercise can decrease levels of pro-inflammatory cytokines and neurotrophins; 
increase GABAergic inhibition; increase the upregulation of analgesic factors; activate the 
descending serotonin inhibitory pathway; and increase the release of endogenous opioids.1,13,26  
In terms of clinical research, only three studies have evaluated the effects of exercise on 
CIPN symptoms in cancer survivors.29,34,63 In one study,63 breast cancer survivors with CIPN 
(n=20) were asked to follow a 10-week home-based exercise program that included walking and 
resistance exercises. The number of survivors who reported unpleasant skin sensations, 
abnormal sensitivity to touch, and sudden bursts of pain decreased following the intervention. In 
the second 12-week study that compared endurance and balance training (n=18) to only 
endurance training (n=19),29 while no between group differences were found in functional 
performance, both groups reported decreases in sensory, motor, and autonomic scores on the 
CIPN20.44 In another study that evaluated the effects of an 8-week multimodal exercise 
intervention on CIPN symptoms and functional deficits in 29 survivors with CIPN,34 significant 
improvements in dynamic balance and CIPN20 symptoms were found following the intervention. 
While sample sizes were small and the exercise interventions were diverse, these findings 
provide preliminary evidence of the beneficial effects of exercise for CIPN. 
Another approach to determine the efficacy of exercise is to evaluate for differences in 
CIPN characteristics in survivors who self-report that they do or do not meet the minimum 
recommended levels of physical exercise (i.e., >150 minutes per week).36 In the first of two 
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studies that used this approach,62 of the 134 women with breast cancer and CIPN, only 15.6% 
reported meeting the physical exercise recommendation. Of note, only 15% of the patients who 
exercised reported experiencing pain compared to 72% of the sedentary patients. In another 
study of colorectal cancer survivors,37 while a definitive diagnosis of CIPN was not confirmed, in 
those survivors who received chemotherapy (CTX; n=506), not meeting the recommended level 
of physical activity was associated with increased rates of CIPN symptoms.  
While these two studies suggested positive relationships between self-reported levels of 
physical activity and decreases in CIPN symptoms,37,62 neither study used both subjective and 
objective measures of CIPN. Therefore, our study aimed to evaluate for differences in 
demographic and clinical characteristics, subjective and objective measures of CIPN, and 
measures of balance among a sample of 290 cancer survivors with CIPN who were classified 
into one of three exercise groups using the recommendation for physical activity from the Office 
of Disease Prevention and Health Promotion’s Healthy People 2020 report.45 We hypothesized 
that lower levels of exercise would be associated with worse scores on subjective and objective 
measures of CIPN and more balance problems. 
Methods 
Survivors and settings 
 The current analysis is part of a larger study, funded by the National Cancer Institute, 
that evaluated CIPN in cancer survivors. The methods for the parent study are described in 
detail elsewhere.35 In brief, survivors were recruited from throughout the San Francisco Bay 
area. Survivors with CIPN met the following inclusion criteria: were >18 years of age; had 
received a platinum and/or a taxane compound; had completed their course of CTX >3 months 
prior to enrollment; had changes in sensation and/or pain in their feet and/or hands of >3 
months duration following the completion of CTX; had a rating of >3 on a 0 to 10 numeric rating 
scale (NRS) for any one of the following sensations from the Pain Quality Assessment Scale 
(PQAS;25 i.e., numb, tender, shooting, sensitive, electrical, tingling, radiating, throbbing, 
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cramping, itchy, unpleasant); if they had pain associated with CIPN, had an average pain 
intensity score in their feet and/or hands of >3 on a 0 to 10 NRS; had a Karnofsky Performance 
Status (KPS) score of >50; and were able to read, write, and understand English. Survivors 
were excluded if they had: peripheral vascular disease, vitamin B12 deficiency, thyroid 
dysfunction, HIV neuropathy, another painful condition that was difficult for them to distinguish 
from their CIPN, a hereditary sensory or autonomic neuropathy, and/or a hereditary 
mitochondrial disorder. Of the 1450 survivors who were screened, 754 were enrolled, and 623 
(i.e., 423 with and 200 without CIPN) completed the self-report questionnaires and the study 
visit. For this analysis, complete data on regular exercise were available from 290 survivors with 
CIPN. 
Study procedures 
 Research nurses screened and consented the survivors over the phone; sent and asked 
them to complete the self-report questionnaires prior to their study visit; and scheduled the in 
person assessment. At this assessment, written informed consent was obtained, questionnaires 
were reviewed for completeness, and objective measurements were done. 
Study Measures 
Demographic and clinical characteristics – Survivors provided information on demographic 
characteristics and completed the Alcohol Use Disorders Identification Test,3 the KPS scale,27 
and the Self-Administered Comorbidity Questionnaire (SCQ).48 
Evaluation of regular exercise Survivors completed a 6-item exercise questionnaire that asked 
them to report whether or not they exercised on a regular basis; what types of physical activity 
they engaged in at the present time (e.g., walk, swim); how many days per week they exercised; 
how many times per day they exercised; as well as the duration and intensity of each session. 
Based on responses to this questionnaire, three exercise groups were created (i.e., no exercise 
(NoEx); <150 minutes per week (LessEx); >150 minutes per week (RecEx)).  
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Pain questionnaires – Separate assessments were completed for pain intensity and quality 
ratings for the hands and feet. A detailed history of CIPN was obtained using a questionnaire 
from our previous30,43 and ongoing studies. Information was obtained on the date of onset of 
pain and its level of interference with function. Average and worst pain intensity over the past 24 
hours were assessed using 0 (no pain) to 10 (worst pain imaginable) NRS.14 
 The 20-item PQAS was used to assess the qualities associated with CIPN.24,25 Sixteen 
items evaluated the magnitude of the different pain quality descriptors (e.g., sharp, hot, aching, 
cold) measured on a 0 to 10 NRS. Four items evaluated global and spatial qualities of pain. The 
PQAS has well established validity and reliability in studies of various types of neuropathic 
pain.24,25 
Sensation – Light touch was evaluated using Semmes Weinstein monofilaments.5 Cold 
sensation was evaluated using the Tiptherm Rod.40,60 Pain sensation was evaluated using the 
Neurotip.40 Vibration threshold was assessed using a biothesiometer.16 For all of the measures 
of sensation, both the upper and lower extremities on the dominant side were tested. 
Balance – Self-report questions from the Chemotherapy-Induced Peripheral Neuropathy 
Assessment Tool (CIPNAT) were used to assess balance.59 The objective measures of balance 
were the Timed Get Up and Go test (TUG)33 and the Fullerton Advanced Balance (FAB) 
test.21,47 
Data analysis 
 Data were analyzed using SPSS version 23.53 Descriptive statistics and frequency 
distributions were calculated for survivors’ demographic and clinical characteristics. For the four 
measures of sensation (i.e., light touch, cold, pain, vibration), composite scores, over all of the 
sites that were tested on the dominant upper and lower extremities, were created. For light 
touch, cold, and pain, the number of sites with loss of each sensation were summed. For 
vibration, the mean score across the sites was calculated.  
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The three exercise groups were created using the survivors’ responses to the exercise 
questionnaire. Survivors who responded no to the question about whether or not they exercised 
on a regular basis were assigned to the NoEX group. The remaining two groups (i.e., survivors 
who exercised <150 minutes per week (LessEx) and survivors who exercised for the 
recommended >150 minutes per week (RecEx)) were assigned based on a calculation of the 
number of times they exercised per week, the number of times per day that they exercised, and 
the duration of the exercise sessions.  
Differences among the three exercise groups in demographic and clinical characteristics, 
as well as subjective and objective measures of CIPN, were evaluated using analyses of 
variance, Chi square analyses, or Kruskal-Wallis tests. For the Bonferroni corrected post hoc 
contrasts, a p-value of <0.0167 (i.e., 0.05/3) was considered statistically significant. 
Results 
Classification of the Exercise Groups 
 Of the 290 survivors with CIPN who completed the exercise questionnaire, 20.7% were 
classified in the NoEx group, 44.5% in the LessEx group, and 34.8% in the RecEx group. As 
shown in Figures 1A to ID, compared to the RecEx group, patients in the LessEx group, 
exercised for fewer minutes per session as well as for fewer total minutes per week and 
participated in less intense exercise and for fewer days per week (all, p<.001). Figure 2 
illustrates the differences in the percentages of patients in the two exercise groups who 
engaged in different types of exercise. 
Differences in Demographic and Clinical Characteristics 
As shown in Table 1, compared with the RecEx group, survivors in the NoEx group had 
completed significantly fewer years of education and were less likely to be married or partnered. 
In addition, compared to the other two exercise groups, survivors in the NoEx group had 
significantly lower annual household incomes.  
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In terms of clinical characteristics (Table 2), compared to the other two groups, survivors 
in the NoEx group had a significantly lower KPS score and a higher BMI. In addition, compared 
to the RecEx group, survivors in the NoEx group had a significantly higher number of 
comorbidities and a higher SCQ score.  
Differences in Self-Reported Pain Characteristics 
 In terms of pain characteristics (Table 3), no differences were found among the exercise 
groups in terms of duration of CIPN and pain intensity scores. However, in terms of interference 
scores in the lower extremities, compared to the RecEx group, survivors in the NoEx group 
reported significantly higher interference scores for balance, walking ability, normal work, sleep, 
and overall interference. In addition, compared to the other two groups, survivors in the NoEx 
group reported significantly higher interference scores for enjoyment of life. In terms of pain 
interference scores in the upper extremities, compared to the RecEx group, survivors in the 
NoEx group reported significantly higher interferences scores for enjoyment of life and sleep.  
 Table 3 summarizes the differences among the three exercise groups in pain quality 
scores in the upper and lower extremities. In terms of the lower extremities, compared to the 
RecEx group, survivors in the NoEx group reported significantly higher PQAS scores for the 
following qualities: unpleasant, intense, aching, throbbing, and intense surface pain. Compared 
with the LessEx group, the NoEx group reported significantly higher PQAS scores in the lower 
extremity for throbbing and tender qualities. For the upper extremities, no significant differences 
were found among the three groups for any of the PQAS scores. 
Differences in Objective Measures of Sensation 
As shown in Table 4, compared to the RecEx group, survivors in the NoEx group had 
significantly higher vibration scores in the lower extremities. No statistically significant 
differences were found among the three exercise groups for any of the other objective 
measures of sensation. 
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Differences in balance 
 In terms of objective measures of balance (Table 4), compared with the RecEx group, 
survivors in the NoEx group had significantly higher TUG scores. In addition, compared to the 
other two groups, survivors in the NoEx group had significantly lower FAB scores. Compared to 
survivors in the RecEx groups, survivors in the LessEx group had significantly lower FAB 
scores.  
Discussion 
This study is the first to evaluate for differences in demographic and clinical 
characteristics, subjective and objective measures of CIPN, and measures of balance among 
cancer survivors with CIPN who were categorized using self-reported levels of exercise. 
Consistent with prior reports,29,34,37,63 our findings support our hypothesis that lower levels of 
exercise would be associated with worse scores for both subjective and objective measures of 
CIPN, as well as more problems with balance. Compared to the survivors who met the Healthy 
People 2020 exercise recommendation,45 survivors in the NoEx group had worse scores for the 
majority of the measures.  
Given that the majority of the differences were found between the NoEx versus the 
RecEx, it is possible that some level of physical activity is beneficial to survivors with CIPN. 
However, when we evaluated, using data from the LessEx and RecEx groups, the relationships 
between the total number of minutes of exercise and worst pain intensity, pain interference, 
TUG, and FAB scores, no “dose response” effect was found for worst pain (Supplemental 
Figure 3A) or pain interference (Supplemental Figure 3B). For TUG (r=-.174, p=.008; 
Supplemental Figure 3C) and FAB (r=.191, p=.004, Supplemental Figure 3D) scores, while 
statistically significant, the correlations were extremely small. The actual “dose” of exercise that 
is sufficient to decrease CIPN signs and symptoms and improve balance remains to be 
determined. 
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In our study, while 34.8% of the survivors reported that they exercised for >150 minutes 
per week, this percentage is lower than the 87.7% reported in a Dutch registry study,37 but 
higher than the 15.7% reported by breast cancer survivors with CIPN in the United States.62 Our 
findings are consistent with previous studies of cancer survivors that found that self-reported 
rates of physical activity ranged from 30% to 37%.4,42  
Compared to the RecEx group, survivors in the NoEx group had fewer years of 
education, were less likely to be married or partnered, and reported a lower annual household 
income. While these characteristics were not evaluated in previous CIPN studies,29,37,63 
evidence from the general population suggests that these same demographic characteristics 
are associated with lower levels of exercise.6 In several studies,2,12,23 lacking someone to help 
motivate an individual to exercise and not having sufficient resources to join a gym or exercise 
group, as well as lack of time were cited as significant barriers to increasing physical activity. 
Consistent with previous studies, compared to the other two exercise groups, survivors 
in the NoEx group had a higher BMI4,7 and poorer functional status.57 However, for all of our 
exercise groups, their BMIs were in the overweight range.9 In terms of functional status, the 
decrement found between the RecEx and NoEx groups represents not only a statistically 
significant but a clinically meaningful decrease in KPS score (i.e., Cohen’s d=0.7). In addition, 
and consistent with reports from the general population,41,46 compared to the RecEx group, 
survivors in the NoEx group had a worse comorbidity profile. While no differences were found 
among our exercise groups in the occurrence rates for specific comorbidities, as noted in recent 
reports regarding the need to tailor exercise regimens for various chronic conditions,20,41 
clinicians need to identify survivors who warrant referrals to physical therapy. These therapists 
can develop exercise interventions that accommodate not only the deficits associated with CIPN 
but those that are required for other chronic conditions. It should be noted that no differences 
were found among our exercise groups in the types of CTX regimens and doses of neurotoxic 
drugs the survivors received. 
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This study is the first detailed examination of the associations between a comprehensive 
set of subjective measures of CIPN (i.e., duration, intensity, qualities, interference) and self-
reported levels of exercise. It is difficult to compare findings across previous studies of self-
reported exercise37,62 because of the variability in the subjective measures that were used. 
While we found no differences among our exercise groups in the duration of CIPN and the 
severity of upper and lower extremity pain, these findings require confirmation because none of 
the previous studies reported on differences in either of these characteristics. Findings 
regarding the effects of exercise on pain intensity in oncology patients58 and patients with 
chronic pain17,38 are inconsistent. For example, in two studies of oncology patients, one found a 
decrease18 while the other found no change11 in pain intensity. In the two reviews of the effects 
of exercise on chronic non-cancer pain,17,38 the authors suggested that the effects of exercise 
on pain intensity were inconsistent and were dependent on both the type of exercise and the 
type of chronic pain evaluated. 
While no differences were found among the exercise groups in any of the pain quality 
scores in the upper extremities, consistent with previous reports,15,29,37 compared to the RecEX 
group, survivors in the NoEx group reported higher scores for unpleasant, intense, aching, and 
throbbing. The lack of effect of exercise on pain qualities in the hands may be partially explained 
by the fact that the most common type exercise in our study was walking which is not likely to 
have an effect on symptoms in the upper extremities. 
Compared to the RecEX group, survivors in the NoEX group reported higher pain 
interference scores in their lower extremities for sleep, enjoyment of life, normal work, walking 
ability, and balance and in their upper extremities for enjoyment of life and sleep. While prior 
studies reported significant improvements in CIPN20 scores associated with exercise,29,37 no 
studies have used the interference items from the Brief Pain Inventory (BPI). While we adapted 
one of the BPI items to assess the effects of CIPN on upper extremity function (i.e., interference 
with routine activities like dressing, toileting, typing), additional research is needed using items 
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that are more specific to hand- and arm-related activities (e.g., manipulation of small objects), 
as well as exercises that are tailored for the upper extremities. 
Of all of the objective measures of sensation that were evaluated, vibration was the only 
one that demonstrated significant between group differences. Compared to the RecEx group, 
survivors in the NoEx group had higher vibration thresholds in the lower extremities. These 
findings are consistent with a pilot study that found significant improvements in vibration 
thresholds but no differences in light touch sensation in oncology patients randomized to either 
sensorimotor training or whole body vibration training.55 
While between 64.4% (RecEx) and 81.7% (NoEx) of the survivors reported balance 
problems that were moderately severe, frequent, and distressing, no differences were found 
among the exercise groups in their self-reports of balance problems. However, compared to the 
RecEX group, survivors in the NoEx group had worse scores on both the TUG and FAB tests. 
Our results are consistent with the findings from a systematic review on the effects of exercise 
in patients with CIPN undergoing active treatment,15 as well as findings in the geriatric literature 
that demonstrate that exercise decreases the risk of falls.19,51 
Limitations 
Several limitations warrant consideration. In this study, because only survivors who had 
received platinum- and/or taxane-containing regimens were evaluated, we cannot determine 
whether these findings generalize to survivors who received other types of neurotoxic CTX. The 
cross-sectional nature of this study limits our ability to determine causal associations between 
various CIPN characteristics and levels of physical activity. While levels of exercise prior to and 
during CTX were not evaluated, findings from one study suggest that level of physical activity 
prior to a cancer diagnosis is a strong predictor of activity up to 10 years post-diagnosis.32 While 
self-reported levels of exercise, rather than objective measures of exercise, are susceptible to 
recall and social desirability biases,8 self-reported physical activity is moderately correlated with 
data obtained using an accelerometer.31,39,52 
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Conclusions 
Despite these limitations, our findings suggest that the lack of regular exercise in cancer 
survivors is associated with worse scores on both subjective and objective measures of CIPN 
and objective balance scores. With the projected increase in the number of cancer survivors in 
the United States to 20 million by 2026,36 as well as the lack of effective treatments for 
numbness, tingling, and pain associated with CIPN,22 it is critical to evaluate cost effective and 
readily available strategies (e.g., walking) to improve CIPN symptoms and balance problems. A 
growing body of evidence suggests that both patients and survivors can safely engage in 
moderate amounts of exercise during and after cancer treatment.49,50,54 Based on our “real world 
findings”, as well as the findings from a limited number of studies on the efficacy of exercise for 
CIPN symptoms and balance problems that suggest benefits,1,29,34 clinicians can recommend 
walking as a therapeutic option, as well as provide referrals to physical therapy for additional 
strength and balance training. Prospective longitudinal studies are needed to determine the 
“optimal dose” and types of exercise that are needed to prevent and treat CIPN symptoms and 
balance problems. In addition, preclinical and clinical studies are warranted to determine the 
mechanisms that underlie the therapeutic benefits of exercise for CIPN. 
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Figure 1 – Differences between the <150 minutes per week (LessEx) and >150 minutes per 
week (RecEx) of recommended exercise groups in minutes per session (A), frequency of 
exercise (B), exercise intensity (C), and minutes of exercise per week (D). 
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Figure 2 – Differences between the <150 minutes per week (LessEx) and >150 minutes per 
week (RecEx) of recommended exercise groups in the types of exercise used. 
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